Background/Aims: Inflammation is an essential component of innate immunity against pathogens, but is tightly regulated, such as by Krüppel-like factor 4 (Klf4), to prevent injury. Klf4 also regulates macrophage polarization, although the mechanisms underlying both functions are poorly understood. The aim of this study was to investigate whether and how Klf4 prevents unregulated inflammation. Methods: The bone marrow-derived macrophages and RAW264.7 cell line were used. Quantitative real-time PCR was used to determine inflammatory cytokines (IL-1β, TNF-α, IL-6 and MCP-1), Klf4 and MCPIP1 transcript levels. Extraction of nuclear and cytoplasmic proteins and Immunoblotting were used to determine Klf4, MCPIP1, relative kinases from NF-κB pathway and K63-linked polyubiquitins expression in nucleus and cytoplasm separately. Dual luciferase reporter assay was used to analyze whether Klf4 mediate MCPIP1 transcription. Immunoprecipitation was used to determine the protein interaction among Klf4, MCPIP1, TRAF6 and K63-linked polyubiquitins. Secretion of IL-1β and TNF-α into sera in mice was measured by Enzyme-linked immunosorbent assay. Results: We found that exposure to lipopolysaccharides suppresses Klf4 expression, even as it induces release of proinflammatory cytokines. Strikingly, Klf4 overexpression significantly lowered cytokine secretion and NF-κB signaling in the cytoplasm following exposure to lipopolysaccharide, even though Klf4 was exclusively nuclear. The cytoplasmic effects are likely mediated by MCP-1 induced protein 1 (MCPIP1), a deubiquitinase and a key modulator of inflammation that accumulates both in the nucleus and cytoplasm in response to Klf4. Indeed, binding between MCPIP1 and K63 polyubiquitins is attenuated in macrophages overexpressing Klf4, suggesting that MCPIP1 is an intermediator induced by Klf4 in the nucleus to remove K63 polyubiquitins from TRAF6 in the cytoplasm, and thereby impede NF-κB and inflammatory signaling. Importantly, Klf4
Plasmids and siRNAs pGMLV-ZsGreen1, pGMLV-Klf4, pGMR-TK, and pGL3-MCPIP1-Luc were purchased from Hegu Science & Technologies. Mouse MCPIP1 siRNAs were purchased from Biomics Biotechnologies, and used at 20 μM by dilution in DEPC-treated water.
Antibodies
Antibodies to MCPIP1 (1:1, 000, #25009-1-AP), Klf4 (1:500, #11880-1-AP), H2AFY2 (1:1, 000, #17030-1-AP), and α-tubulin (1:1, 000, #11224-1-AP) were purchased from Proteintech, along with mouse anti-rabbit IgG light chain (1:5, 000, #SA00001-7). Anti-IKKγ (phospho ser85) (1:1, 000, #GTX32283) was purchased from GeneTex, while antibodies to IKKα/β (phospho Ser176/180) (1:1, 000, #2697S), TAK1 (1:1, 000, #5206), and TAK1 (phospho Thr184/187) (1:1, 000, #4511) were procured from Cell Signaling Technology. Antibodies to K63-linked ubiquitin (1:1, 000, #ab179434), TRAF6 (1:1, 000, #ab94720), NF-κB p65 (1:1, 000, #ab16502), IKKα/β (1:1, 000, #ab178870), and IKKγ (1:5, 000, #ab178872) were obtained from Abcam. Rabbit polyclonal antibodies to GAPDH (1:1, 000, #R1208-3), and goat anti-rabbit IgG (1:5, 000, #EK020) were obtained from Zhuangzhi Biotech.
Transient transfection RAW264.7 macrophages grown to 60-80 % confluence were transfected for 24 h or 48 h with pGMLVZsGreen1, pGMLV-Klf4, pGMR-TK, or pGL3-MCPIP1-Luc in Opti-MEM (Thermo Gibco; #31985062) and Lipofectamine 3000 Reagent (Thermo Invitrogen; #L3000008), following the manufacturer's instructions. To silence MCPIP1, RAW264.7 macrophages grown to 60-80 % confluence were transfected with siRNAs or scrambled siRNAs at a 1:1 v:v mixture with Micropoly-transfector cell reagent (Micropoly; #MT110), following the manufacturer's instructions. After 48 h, cells were stimulated with 1 μg/mL lipopolysaccharide, and analyzed for mRNA or protein levels of relevant molecules.
Dual luciferase reporter assay RAW264.7 cells at 60-80 % confluence were seeded in a 24-well plate, and co-transfected with pGL3-MCPIP1-Luc, pGMLV-ZsGreen1 (NC) or pGMLV-Klf4 (Klf4), and pGMR-TK at a ratio of 10:9:1. After 24 h, cells were washed with DPBS (Corning Cellgro; #21-031-CVR) and lysed in passive lysis buffer. Luciferase activity was measured in the lysate by the Dual Luciferase Reporter Assay System (Promega; #E1910) according to the manufacturer's instructions, and normalized to Renilla luciferase. Data were collected in triplicate from at least two experiments. 
RNA isolation and quantitative real-time PCR
Total RNA was extracted from cells or tissues using TRIzol Reagent (Thermo Invitrogen; #15596-026) in accordance with the manufacturer's protocol. RNA extracts with OD260/280 ratio 2.0 (0.5 mg) were reverse-transcribed by PrimeScript RT Master Mix (TaKaRa, #RR036A) at 37 °C for 15 minutes and at 85 °C for 5 seconds. Targets were then amplified in triplicate by quantitative RT-PCR using SYBR Green PCR Master Mix (TaKaRa; #RR820A) on a Bio-Rad iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad), normalized to GAPDH, and quantified by the comparative cycle threshold method (2 ΔΔCT ). Primer sequences are listed in Table 1 .
Protein isolation and immunoblotting
Cells were washed with ice-cold DPBS, lysed on ice for 30 minutes with RIPA buffer (HEART Biological Technology; #WB009), and centrifuged at 12, 000 rpm for 10 minutes. Total protein was measured by BCA Protein Assay Kit (Thermo Scientific; #23225), mixed with 5× SDS-PAGE loading buffer (HEART Biological Technology; #R0993), and heated at 100 °C for 10 minutes. Samples (40 μg) were resolved by SDS-PAGE (HEART Biological Technology; #WB005), and immunoblotted with corresponding antibodies.
Extraction of nuclear and cytoplasmic proteins
Cells were lysed using Nuclear and Cytoplasmic Protein Extraction Kit (Yeasen; #20126ES50) in accordance with the manufacturer's protocol, and fractions were immunoblotted with appropriate antibodies.
Immunoprecipitation
Cells were lysed on ice for 30 minutes in Immunoprecipitation RIPA buffer (HEART Biological Technology; #WB065) emented with protease inhibitor, centrifuged at 12, 000 rpm for 10 minutes, and immunoprecipitated with Protein A/G PLUS-Agarose Immunoprecipitation Reagent (Santa Cruz; #SC-2003) according to the manufacturer's instructions. Briefly, lysates were precleared by incubating on ice for 30 minutes with 1 µg control IgG and 20 µL Protein A/G PLUS-Agarose. Beads were pelleted by centrifugation at 2, 500 rpm for 5 minutes at 4 °C. The resulting supernatant (approximately 100-500 µg total protein) was incubated with 1 µg primary antibody for 1 h, and then with 20 µL Protein A/G PLUS-Agarose overnight at 4 °C. Immunoprecipitates were collected by centrifugation at 2, 500 rpm for 5 minutes at 4 °C, washed 4 times with Immunoprecipitation RIPA buffer, resuspended in 40 µL 1× loading buffer, and boiled for 10 minutes. Samples (20 μL) were then resolved by SDS-PAGE and immunoblotted with appropriate antibodies.
Enzyme-linked immunosorbent assay (ELISA)
Mice were anesthetized by intraperitoneal injection of 1 % pentobarbital sodium (5 mL/kg). Blood was collected from the eyes, and centrifuged at 3, 000 rpm for 10 min. TNF-α (#EMC102a.48) and IL-1β (#EMC001b.48) in sera were quantified in triplicate by mouse ELISA kits according to the manufacturer's instructions (Neobioscience).
Statistical analysis
Data were analyzed in GraphPad Prism version 4.0 (GraphPad Software, La Jolla, CA, USA). Each experiment was repeated at least three times, and data are reported as mean ± standard error of the 
Results

Klf4 is an essential inhibitor of inflammation
As innate immune cells, macrophages represent the first line of defense. These cells are highly plastic, and acquire various phenotypes in response to environmental cues [5] . In mouse RAW264.7 and bone marrow-derived macrophages exposed to 1 μg/ mL lipopolysaccharide and characterized at 0 h, 0.5 h, 1 h, 2 h, 6 h, 12 h, and 24 h ( Fig. 1 A  and B) , the pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and MCP-1 were upregulated to various extents, peaking at about 2 h after stimulation. These data confirm that macrophages are activated and acquire a pro-inflammatory phenotype in response to lipopolysaccharides.
On the other hand, Klf4 plays importment roles in macrophage polarization and innate immunology regulation. However, the mechanisms by which Klf4 regulates inflammation are not fully understood. Strikingly, Klf4 mRNA and protein levels were significantly attenuated in RAW264.7 and bone marrow-derived macrophages exposed to lipopolysaccharides. Indeed, Klf4 expression reached the lowest levels about 2 to 6 hours after stimulation, and coincided with upregulation of pro-inflammatory genes ( Fig. 1 A-D) .
We then constructed a plasmid (pGMLV-Klf4) to overexpress Klf4 in RAW264.7 macrophages, with pGMLV-ZsGreen1 as negative control (Fig. 1 E-G) . As shown in Fig. 1 H, activation of pro-inflammatory marker genes following exposure to lipopolysaccharide was significantly ameliorated in macrophages overexpressing Klf4, indicating strong antiinflammatory activity. These results collectively show that Klf4 expression diminishes in parallel to lipopolysaccharide-mediated activation of pro-inflammatory genes, while Klf4 overexpression blocks the effects of lipopolysaccharide. Nuclear Klf4 suppresses cytoplasmic NF-κB signaling Furthermore, we found that phosphorylation of molecules in the NF-κB pathway, including TAK1, IKK-α/β, and IKK-γ, was significantly enhanced in macrophages treated with 1 μg/mL lipopolysaccharide for various durations. In line with this result, expression of K63-linked polyubiquitins was also enhanced (Fig. 2 A and B) . Strikingly, activation of these kinases in response to lipopolysaccharide was less pronounced in RAW264.7 macrophages transiently transfected for 48 h with pGMLV-Klf4 to overexpress Klf4 (Fig. 2 B) . We note that bone marrow-derived macrophages were inefficiently transfected, and were thus unsuitable for similar analysis.
Klf4 accumulated exclusively in the nucleus under basal conditions or under lipopolysaccharide stimulation, while IKK complexes and TAK1 were cytoplasmic. Further, Klf4 expression reduced the translocation of p65 to the nucleus following exposure to lipopolysaccharide (Fig. 2 C) . Collectively, these results indicate that Klf4 ameliorates NF-κB signaling only indirectly.
Klf4 mediates MCPIP1 transcription to regulate NF-κB
The deubiquitinase MCPIP1 inhibits NF-κB activation, and is driven by a promoter that contains multiple Klf4 sites [32] . As shown in Fig. 3 A to C, transcript and protein levels of MCPIP1 were both elevated in RAW264.7 macrophages transiently overexpressing Klf4, implying that Klf4 boosts MCPIP1 expression. Similarly, RAW264.7 macrophages transfected with a dual luciferase reporter vector under the control of the MCPIP1 promoter, expressed luciferase only upon Klf4 overexpression (Fig. 3 D) . Moreover, immunoblotting of subcellular fractions revealed that MCPIP1 accumulates both in the nucleus and cytoplasm, and is upregulated upon Klf4 overexpression under both basal conditions and under lipopolysaccharide stimulation. Klf4 overexpression also reduced p65 translocation to the nucleus following exposure to lipopolysaccharide (Fig. 3 E and F) . Together, these results indicate that Klf4 regulates the expression of MCPIP1, which then translocates to the cytoplasm to regulate NF-κB. [12, 24] . In line with this model, we found that exposure to lipopolysaccharide dramatically enhanced MCPIP1 expression in macrophages, as shown in Figure 4 A to C, especially at 2 to 6 hours after exposure. We then synthesized three small interfering RNAs against MCPIP1 (siMCPIP1), of which siMCPIP1-2 and siMCPIP1-3 markedly reduced MCPIP1 expression after transient transfection for 48 h, in comparison to scrambled siRNA (siNC). In cells transfected with siMCPIP1-3 for 48 h (Fig. 4 D to F) , the pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and MCP-1 were notably upregulated at mRNA levels both in normal conditions and in response to lipopolysaccharide (Fig. 4  G) , suggesting that MCPIP1 knockdown elicits hyperinflammation. In addition, IKK complexes, TAK1, and K63-linked polyubiquitins were elevated to various extents in macrophages transfected with siMCPIP1-3 for 48 h and then challenged with 1 μg/mL lipopolysaccharide for 0, 30, 60, and 180 min (Fig. 4 H) . Taken together, these results indicate that MCPIP1 suppresses the inflammatory response to lipopolysaccharide by modulating NF-κB signaling.
Klf4 indirectly inactivates TRAF6 via MCPIP1
Recent studies identified TRAF proteins as essential in the response to lipopolysaccharide. For example, binding of lipopolysaccharide to TLR4 triggers recruitment of MyD88 and IRAK1/4, which subsequently recruit TRAF6 to initiate downstream signaling [6] . In RAW264.7 macrophages transfected with negative control or Klf4 plasmid for 48 h and then A-C. MCPIP1 (A) mRNA levels and (B and C) protein levels in RAW264.7 macrophages after transient transfection of plasmid pGMLV-Green1 as negative control (NC) or pGMLV-Klf4 (Klf4) for 48 h, and normalized against GAPDH. D. RAW264.7 macrophages were cotransfected with MCPIP1 promoter luciferase reporter vector pGL3-MCPIP1-Luc, pGMLV-Green1 (NC)/ pGMLV-Klf4 (Klf4) and pGMR-TK at ratio 10﹕9﹕1 for 24 h, and luciferase activity was measured in the lysate by the Dual-luciferase reporter Assay System and normalized to Renilla luciferase assay. Overxpression of Klf4 enhanced MCPIP1 luciferase reporter activity. E and F. Cytoplasmic and nuclear extracts of NC and Klf4 overexpressed Raw264.7 macrophages that either uninfected or infected with LPS for 2 h were analyzed by immunoblotting for MCPIP1, Klf4, P65, H2A and α-tubulin. Purity of cytoplasmic and nuclear fraction is depicted by α-tubulin and H2A as loading control. Data are shown as mean ± SEM. * p<0.05, ** p<0.01 vs. negative control. Data are representative of at least three independent experiments.
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Cellular Physiology and Biochemistry stimulated with lipopolysaccharide, we found by immunoprecipitation that Klf4 coprecipitates with MCPIP1, but not with TRAF6 or K63-linked polyubiquitins (Fig.  5 A) . Moreover, we found that TRAF6 coprecipitates with K63 polyubiquitins and MCPIP1, but not with Klf4, and that accumulation of K63 polyubiquitins was lower in cells overexpressing Klf4 (Fig. 5 B) . Moreover, pulldown experiments showed that cytoplasmic MCPIP1 was in complex with TRAF6 and K63 polyubiquitins, but not with Klf4. On the other hand, nuclear MCPIP1 was associated with Klf4, but not TRAF6 and K63 polyubiquitins (Fig.  5 C) . Together, these data imply that increased Klf4 expression elevates MCPIP1 activity in the nucleus to attenuate TRAF6 deubiquitination in the cytoplasm, and thereby suppress NF-κB signaling in response to lipopolysaccharide (Fig. 7) .
Klf4 overexpression in vivo alleviates inflammation in septic mice
The role of Klf4 in inflammation was investigated in vivo using mice transfected for five days with pGMLVZsGreen1 or pGMLV-Klf4 by injection through the caudal vein. These mice were then treated with 15 mg/kg lipopolysaccharide by intraperitoneal injection. We found that survival 48 h after exposure was higher in mice overexpressing Klf4 (approximately 70 %) than in mice transfected with pGMLV-Green1 (approximately 40 %, Fig. 6 A) . Moreover, secretion of inflammatory cytokines into sera, including TNF-α and IL-1β, was wellcontrolled in mice overexpressing Klf4 6 h after exposure to lipopolysaccharide (Fig. 6 B) . Analysis of the liver, lungs, and kidney, which are the organs most susceptible to septic injury, indicated that although Klf4 mRNA levels in the kidney were comparable among groups, levels in the liver and lungs were > 200-and 15-fold higher in mice overexpressing Klf4 than in control mice (Fig. 6C) , regardless of exposure to lipopolysaccharide. However, lipopolysaccharide-induced expression of pro-inflammatory mRNAs in the liver, including TNF-α, IL-1β, The mice survival is represented in a Kaplan-Meier plot. Statistical analysis on survival curves were performed using log-rank test. B. mice transfected with NC (n = 5) or Klf4 (n = 5) were inoculated via intraperitoneal route with saline or LPS (15 mg/kg). 6 h later, sera were analyzed by enzyme-linked immuno sorbent assay (ELISA) for TNF-α and IL-1β levels. C. qRT-PCR analysis of transcript for Klf4 gene in livers, lungs and kidneys of mice transfected with NC (n = 6) or Klf4 (n = 6) 6 h after inoculation of LPS. D and E. qRT-PCR analysis of transcripts for inflammatory cytokines TNF-α, IL-1β, IL-6 and MCP-1 genes in livers (D) and lungs (E) of mice transfected with NC (n = 6) and Klf4 (n = 6) 6 h after inoculation of LPS. Data are shown as mean ± SEM. * p<0.05, ** p<0.01 vs. negative control.
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Cellular Physiology and Biochemistry IL-6, and MCP-1, was remarkably lower in the former (Fig.  6D) . Similar results, except IL-6, were observed in the lungs (Fig.  6E ), but not in the kidney (data not shown). Together, these data show that Klf4 is an important inhibitor of the inflammatory response, and partially protects mice from lipopolysaccharide-induce sepsis.
Discussion
Infection by bacteria, viruses, fungi, parasites, and other pathogens elicit local and systemic inflammatory responses [37, 38] , of which sepsis is a leading cause of mortality in adults and children [39, 40] . Since inflammation and innate immunity against bacteria are hallmarks of sepsis [41, 42] , enhancing the latter while mitigating the former is a worthwhile therapeutic strategy [43] . One possibility is to exploit Klf4, a zinc-finger transcription factor that was shown to either promote [44, 45] or inhibit inflammatory signaling [33, 46] . In light of these contradictory results, we now present strong evidence that Klf4 overexpression, at least under our experimental conditions, significantly suppresses the inflammatory response of macrophages to lipopolysaccharide, markedly decreasing the release of pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and MCP-1. Nevertheless, further in vivo experiments in animals and even in humans are still needed to conclusively demonstrate that Klf4 is anti-inflammatory.
Importantly, Klf4 appears to inhibit lipopolysaccharide-induced inflammation via NF-κB, as evidenced by a dramatic decrease in phosphorylation of TAK1, IKKα/β, and IKKγ, as well as in the expression of K63 polyubiquitin chains. However, we also found that while the affected proteins are cytoplasmic, Klf4 is nuclear. Immunoprecipitation also indicated that Klf4 did not bind any of the affected proteins, implying that Klf4 does not directly regulate NF-κB effector proteins. Subsequently, we found the Klf4 avidly binds MCPIP1, which, in turn interacts with a protein upstream to NF-κB such as TRAF6. Indeed, MCPIP1 was previously shown to inhibit lipopolysaccharide-induced JNK and NF-κB signaling by deubiquitinating TRAF proteins [2, 12, 22] . Strikingly, MCPIP1 is itself induced during inflammation [32] , and by inflammatory signals such as NF-κB, IL-1b, TNF-a, and IL-6 [8, 27] , although it is not clear how MCPIP1 is regulated, or whether it provides negative feedback regulation. We believe that such a feedback mechanism is likely. Indeed, we observed that Klf4 overexpression also upregulates MCPIP1 both at the mRNA and protein level, and that Klf4 stimulates expression of a luciferase reporter gene controlled by the MCPIP1 promoter. In addition, our data also indicate that loss of MCPIP1 significantly enhances the release of the pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and MCP-1, reinforcing that notion that MCPIP1 is anti-inflammatory. Therefore, Klf4 appears to modulate lipopolysaccharide-induced inflammation via MCPIP1.
In line with in vitro data, mice overexpressing Klf4 were less sensitive to lipopolysaccharide, secreting lower levels of pro-inflammatory cytokines into sera, including TNF-α and IL-1β, in response to exposure. Most importantly, Klf4 overexpression ameliorated the severity of clinical symptoms (data not shown) and reduced mortality. However, the protective effects of Klf4 were observed only in the lungs and liver, but not in the kidney, even though all three are severely damaged during sepsis. This result correlates with Klf4 levels, which were variable in these tissues perhaps as a result of variable dissemination of the plasmid. For example, we found that Klf4 overexpression was much stronger in the liver than in the lungs and kidney of the same mice, as was previously observed [47] . In addition, specific cellular conditions or greater reparative capacity in the liver may enhance the effects of Klf4. In any case, these observations suggest that the protective effects of Klf4 against inflammation may differ depending on tissue type. Some major issues remain to be addressed. For example, why is Klf4 suppressed in response to lipopolysaccharide? One possibility is that miR-7 or other factors control Klf4 expression to modulate physiological process in macrophages, which are under study in our group. The mechanisms underlying MCPIP1 upregulation but Klf4 suppression response to lipopolysaccharide should also be clarified. On the other hand, MCPIP1 may also modify Klf4 ubiquitination, and thereby alter its regulatory effects on cellular processes such as cell growth, proliferation, and differentiation [48, 49] . Indeed, Klf4 sumoylation promotes IL-4-induced macrophage M2 polarization [50] . Finally, the long-term effects of Klf4 against lipopolysaccharide-induced inflammation remain unknown.
Taken together, the data demonstrate that Klf4 modulates lipopolysaccharide-induced inflammation and tissue damage both in vivo and in vitro by suppressing the release of proinflammatory cytokines, inducing MCPIP1, and inhibiting NF-κB signaling. Our findings not only provide strong evidence that Klf4 is involved in innate immunity and sepsis, but also highlight new research opportunities into the role of Klf4 in various inflammatory processes and disorders, as well as into its potential as therapeutic target.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
